‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
Beyond the arrhythmia, AF often signals broader pathological processes that impair cardiac function and reduce quality of life and life expectancy.5 Many of these conditions are closely linked to social determinants of health, disproportionately affecting populations with socioeconomic disadvantage. Effective AF management requires addressing both the arrhythmia and its underlying contributors.4 
C – Comorbidity and risk factor management
WarfarinFrom darkness comes light
Earlier this year, retired pharmacist and survivor of domestic violence Julie Griffin MPS was awarded an Order of Australia Medal for her service to...
Listings for biosimilar uptake drivers expanded
Amended prescribing information has been released for two biosimilar uptake drivers listed on the Pharmaceutical Benefits Scheme (PBS), as part of the Biosimilar Awareness...
Budget’s funding welcome, but more is needed for pharmacy
PSA has welcomed the government’s commitment to pharmacy in the 2019-20 Federal Budget through the extension of the Administration Handling and Infrastructure (AHI) fee...
What pharmacists need to know about the early flu outbreak
An early start to flu season might lead patients to seek out the vaccine earlier than usual. But while healthcare practitioners stress the need...
Pharmacists in 2023: Unlocking the opportunity
It’s time for PSA to reveal our vision of the future of pharmacy in Australia.
I am pleased to announce our Pharmacists in 2023...
Medicine safety: The big picture
Dr Libby Roughead MPS is Senior Principal Research Fellow at the University of South Australia’s School of Pharmacy, where her work focuses on quantifying...
